Author

Francisco Hermida‐Prado

Universidad de OviedoORCID 0000-0002-2916-0337Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:organoid / primary culture· 1 Assay:proteomics· 1

Frequent Co-Authors

Beatriz de Luxán‐DelgadoiD· 2 shared Juan Pablo RodrigoiD· 2 shared Juana Maria Garcia-PedreroiD· 2 shared Saúl Álvarez–TeijeiroiD· 2 shared Alejandra García‐TorreiD· 1 shared Ana Martínez‐CarrilloiD· 1 shared Andrea Blazquez· 1 shared Aurora AstudilloiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Beatriz de Luxán‐DelgadoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Functional proteomics identifies targetable cancer-associated fibroblast programs in head and neck cancer

Llara Prieto-Fernández, Ana Martínez‐Carrillo, Lucas de Villalaín, Alejandra García‐Torre, Beatriz de Luxán‐Delgado, Francisco Hermida‐Prado, Inmaculada Navarro‐Lérida, Catalina Ribas, Ramón García‐Escudero, Juan Pablo Rodrigo, Juan Carlos de Vicente, Tania Rodríguez‐Santamarta, Juana Maria Garcia-Pedrero, Saúl Álvarez–Teijeiro

The paper identifies functionally distinct and pharmacologically targetable cancer-associated fibroblast (CAF) programs in head and neck cancer using proteomic and functional assays.

bioRxiv · Aug 21, 2026 · PreprintCancer Biology

PATIENT-DERIVED ORGANOIDS CAPTURE HISTOLOGICAL, MOLECULAR AND THERAPEUTIC HETEROGENEITY IN PHARYNGEAL AND LARYNGEAL SQUAMOUS CELL CARCINOMAS

Miguel Álvarez-González, Esperanza Pozo-Agundo, Beatriz de Luxán‐Delgado, Helena Codina‐Martínez, Borja Gallego, María Otero‐Rosales, Israel Rivera-García, Andrea Blazquez, Mar Rodríguez-Santamaría, Daniela Corte-Torres, Saúl Álvarez–Teijeiro, Sonia Blanco Parajón, Fernando Lopez, Francisco Hermida‐Prado, Rene Rodriguez, , Mónica Álvarez‐Fernández

This study establishes patient-derived organoids from HNSCC tumors that recapitulate histological, molecular, and therapeutic diversity, enabling personalized therapeutic testing.

bioRxiv · Mar 26, 2026 · PreprintCancer Biology